Product Images Nifedipine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Nifedipine NDC 50090-4249 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image1 - image 01

image1 - image 01

image2 - image 02

image2 - image 02

The text describes mean reductions in blood pressure (systolic/diastolic) for different doses of Nifedipine ER tablets in two studies. Study 1 included doses of 30mg, 60mg, and 90mg, while study 2 included the same doses. The number of patients (N) and the mean trough dose reduction is given for each dose. "Placebo response subtracted" is noted, and Nifedipine ER is defined as Nifedipine extended-release tablets.*

image3 - image 03

image3 - image 03

This is a table that compares the percentage of adverse effects in patients taking Nifedipine extended-release tablets versus a placebo. The adverse effects are headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The number of patients included was 370 for Nifedipine and 126 for the placebo.*

Label Image - lbl500904249

Label Image - lbl500904249

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.